UPDATE 2-Nissan CEO Saikawa admits to misconduct in compensation - Jiji
- Country:
- Japan
Nissan Motor Co Chief Executive Hiroto Saikawa admitted to misconduct involving stock-related compensation and said he planned to return the portion he had wrongfully received, Jiji news agency reported.
Saikawa made the comments to reporters on Thursday morning after media reported that an internal company probe had found he had received tens of millions of yen more than he should have through a stock appreciation rights (SAR) scheme. "I am deeply sorry for causing concern," he told reporters, according to Jiji.
The company's investigation came after former Nissan director Greg Kelly went public with the allegations earlier this year. Saikawa is expected to share the results of the probe at a board meeting to be held soon, the Asahi newspaper said. In an interview with magazine Bungei Shunju published in June, Kelly said Saikawa was granted an exception in 2013 to reschedule a stock-linked bonus that bumped up the payout by 47 million yen ($445,962).
The admission is set to further erode confidence in Saikawa, already facing widespread accusations he was too close to ousted boss Carlos Ghosn, who, like Kelly, is awaiting trial on charges of financial misconduct. Both men have denied wrongdoing. Despite promising improved corporate governance and a better standing for Nissan in its relationship with top shareholder Renault SA, Saikawa was re-appointed by shareholders with the lowest approval rating among the 11 directors in June.
Nissan declined to comment on the reports of Saikawa's misconduct or his comments to reporters on Thursday.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
ECI asks editors of newspapers to follow norms while publishing political advertisements
Be cautious in publishing ads masquerading as news item, EC reminds newspapers
UPDATE 1-Australia's Santos shareholders re-elect Keith Spence as chair
Aster board approves spl dividend of Rs 118 per share to shareholders
AstraZeneca shareholders approve 2024 pay policy at AGM